Mind’s role in therapeutics, wellness means opportunity for cognitive assessment technology – FIRST ANALYSIS QUARTERLY INSIGHTS
The increasing burden and costs associated with Alzheimer’s disease and other neurodegenerative diseases have made early diagnosis and intervention a national priority. However, conducting clinical trials to develop therapies for diseases like Alzheimer’s is particularly challenging, contributing to higher costs…